NDAORALTABLET, DELAYED RELEASE
Approved
Apr 2013
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DICLEGIS is a delayed-release oral tablet combining doxylamine succinate and pyridoxine hydrochloride (vitamin B6) for the treatment of nausea and vomiting in pregnancy. The mechanism of action is unknown, but the product has been FDA-approved since 2013 and represents the first prescription treatment for this indication. Doxylamine is absorbed primarily in the jejunum with peak concentrations at 7.2 hours, while pyridoxine metabolites accumulate with repeated dosing.
$0.017BPart D
PeakProduct is at peak revenue stage with modest Part D utilization; team size is minimal based on 1 linked job opening.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Started Feb 2014
131 enrolled
Morning Sickness
Career Relevance
DICLEGIS is associated with minimal career opportunity, with only 1 linked job opening in a non-specialized business support role. This reflects a small, administratively lean team managing a mature, niche product with stable but limited market dynamics.
Office Clerk
Worked on DICLEGIS at Duchesnay? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.